OTCMKTS:NICXF Nicox (NICXF) Stock Price, News & Analysis → The only accurate crypto trading system I know … (From Weiss Ratings) (Ad) Free NICXF Stock Alerts $0.44 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.44▼$0.4450-Day Range$0.44▼$0.4452-Week Range$0.44▼$0.44VolumeN/AAverage VolumeN/AMarket Capitalization$22.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Nicox alerts: Email Address Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. About Nicox Stock (OTCMKTS:NICXF)Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation. It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was incorporated in 1996 and is headquartered in Valbonne, France.Read More NICXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NICXF Stock News HeadlinesApril 24, 2024 | americanbankingnews.comHead to Head Contrast: A.P. Møller - Mærsk A/S (OTCMKTS:AMKBY) and Nicox (OTCMKTS:NICXF)April 23, 2024 | msn.comEXCLUSIVE: Godzilla Store Releases New Clothing Line for Toho's Chibi Godzilla AnimeApril 25, 2024 | Paradigm Press (Ad)Bitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…April 21, 2024 | msn.comJapan Ranks Its Most Popular Anime for Spring 2024 Season So FarMarch 27, 2024 | yahoo.comComical Psychosomatic Medicine Season 1 Streaming: Watch & Stream Online via CrunchyrollMarch 9, 2024 | msn.comThe Perfect Prince Loves Me, the Side Character?! anime unwraps its charms on March 15February 23, 2024 | msn.comHow to Read the Entire Bleach Manga Online in 2024?February 21, 2024 | finance.yahoo.comJapan OTT and Pay TV Sector Forecasts to 2029: In-depth Analysis of Market Trends and Revenue OpportunitiesApril 25, 2024 | Paradigm Press (Ad)Bitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…February 1, 2024 | msn.comAnimeFesta's boys love Series, 'The Perfect Prince Loves Me, His Rival?!,' reveals cast and visualsJanuary 19, 2024 | yahoo.comJulia Michaels Talks ‘Surreal’ Experience Writing Music for Disney’s ‘Wish’January 19, 2024 | yahoo.comMichael Jackson’s Nephew Jaafar Jackson Shares Toe Stand Photo Portraying the Icon in BiopicJanuary 19, 2024 | msn.comCelebrating Saudi Creativity: Swizz Beatz on His Deep Connection to the KingdomJanuary 19, 2024 | yahoo.com12 Albums, 12 Stories: Elissa Revisits the Milestones of Her Journey as the Arab World’s ‘Queen of Emotions’January 19, 2024 | msn.comYukopi Rules Billboard Japan’s ‘NICONICO VOCALOID SONGS TOP20’ Year-End Chart: A Look Back at the 2023 Vocaloid SceneJanuary 12, 2024 | finance.yahoo.comNicox S.A. (ALCOX.PA)January 3, 2024 | msn.comJapan 2011 tsunami clip falsely shared as damage from New Year's Day quakeJanuary 3, 2024 | msn.comWhere To Watch The FF14 Japan Fan Fest 2024December 18, 2023 | markets.businessinsider.comNicox Announces First Patient Screened in the Whistler Phase 3b Trial of NCX 470 in GlaucomaDecember 14, 2023 | finance.yahoo.comNicox’s Announces Publication of New Nonclinical Data Demonstrating More Effective Intraocular Pressure Lowering of NCX 470 compared to LumiganDecember 2, 2023 | morningstar.comNicox SA Share from reverse split ALCOXNovember 26, 2023 | msn.com‘Jujutsu Kaisen’ Singer Eve’s First Asia Tour 2024 Has Singapore As Second StopNovember 13, 2023 | msn.comDoes I Shall Survive Using Potions anime have a manga? ExplainedNovember 11, 2023 | msn.com10 Best Pokémon Anime Openings, RankedNovember 7, 2023 | msn.comNicox SA (NICXF) Upgraded to Buy: Here's What You Should KnowOctober 20, 2023 | msn.comNicox reports Q3 resultsOctober 20, 2023 | markets.businessinsider.comNicox Provides First Half 2023 and Third Quarter 2023 Financial Results and Updates Key MilestonesSee More Headlines Receive NICXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nicox and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:NICXF Previous SymbolNASDAQ:NICXF CUSIPN/A CIKN/A Webwww.nicox.com Phone(349) 724-5300Fax33-4-97-24-53-99Employees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$5.52 million Price / Sales3.99 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book0.40Miscellaneous Outstanding Shares50,100,000Free FloatN/AMarket Cap$22.04 million OptionableNot Optionable Beta0.36 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Michele Garufi Ph.D. (Age 70)Co-Founder & Director Comp: $471.16kDr. Gavin M. Spencer (Age 54)Chief Executive Officer Ms. Sandrine Gestin (Age 57)Vice President of Finance Mr. Doug Hubatsch (Age 57)Executive VP & Chief Scientific Officer Dr. Ramesh KrishnamoorthySenior Director and Head of Late Stage CMC & Quality ControlDr. Jose BoyerConsultantMore ExecutivesKey CompetitorsPoxelOTCMKTS:PXXLFElse NutritionOTCMKTS:BABYFPreveCeutical MedicalOTCMKTS:PRVCFLisata TherapeuticsNASDAQ:LSTAMEI PharmaNASDAQ:MEIPView All Competitors NICXF Stock Analysis - Frequently Asked Questions How have NICXF shares performed in 2024? Nicox's stock was trading at $0.44 at the beginning of 2024. Since then, NICXF stock has increased by 0.0% and is now trading at $0.44. View the best growth stocks for 2024 here. How do I buy shares of Nicox? Shares of NICXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NICXF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nicox S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
